CA Stock MarketDetailed Quotes

MDNA Medicenna Therapeutics Corp

Watchlist
  • 2.110
  • -0.170-7.46%
15min DelayMarket Closed Jun 14 16:00 ET
157.78MMarket Cap-9173P/E (TTM)

Medicenna Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-2.93%4.78M
33.23%5.44M
2.98%4.46M
-27.46%16.3M
-4.99%2.97M
0.49%4.92M
-50.43%4.08M
-30.34%4.33M
29.19%22.47M
-45.24%3.13M
Selling and administrative expenses
-9.63%1.78M
34.07%2.3M
-14.23%1.65M
-9.40%6.99M
-28.25%1.38M
-0.30%1.97M
-12.13%1.72M
3.34%1.92M
19.04%7.72M
-3.50%1.93M
-General and administrative expense
-9.63%1.78M
34.07%2.3M
-14.23%1.65M
-9.40%6.99M
-28.25%1.38M
-0.30%1.97M
-12.13%1.72M
3.34%1.92M
19.04%7.72M
-3.50%1.93M
Research and development costs
1.56%2.99M
32.68%3.13M
16.63%2.81M
-36.78%9.3M
33.17%1.59M
1.31%2.95M
-62.32%2.36M
-44.56%2.41M
35.38%14.72M
-67.82%1.19M
Depreciation amortization depletion
0.00%2K
-50.00%1K
--1K
-86.49%5K
-85.71%1K
-80.00%2K
-80.00%2K
--0
-7.50%37K
-30.00%7K
-Depreciation and amortization
0.00%2K
-50.00%1K
--1K
-86.49%5K
-85.71%1K
-80.00%2K
-80.00%2K
--0
-7.50%37K
-30.00%7K
Operating profit
2.93%-4.78M
-33.23%-5.44M
-2.98%-4.46M
27.46%-16.3M
4.99%-2.97M
-0.49%-4.92M
50.43%-4.08M
30.34%-4.33M
-29.19%-22.47M
45.24%-3.13M
Net non-operating interest income (expenses)
-17.06%282K
111.11%342K
1,053.33%346K
1,224.64%914K
4,144.44%382K
2,025.00%340K
671.43%162K
30.43%30K
-78.03%69K
-66.67%9K
Non-operating interest income
-17.06%282K
111.11%342K
1,053.33%346K
1,224.64%914K
4,144.44%382K
2,025.00%340K
671.43%162K
30.43%30K
-78.03%69K
-66.67%9K
Other net income (expenses)
-114.01%-482K
-54.61%1.37M
762.76%1.25M
3,187.28%5.34M
-1,339.77%-1.27M
4,548.65%3.44M
8,791.18%3.02M
175.13%145K
16.83%-173K
32.82%-88K
Gain on sale of security
-114.01%-482K
-54.61%1.37M
762.76%1.25M
3,187.28%5.34M
-1,339.77%-1.27M
4,548.65%3.44M
8,791.18%3.02M
175.13%145K
16.83%-173K
32.82%-88K
Income before tax
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
34.94%-4.16M
-30.59%-22.58M
44.86%-3.21M
Income tax
Earnings from equity interest net of tax
Net income
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
34.94%-4.16M
-30.59%-22.58M
44.86%-3.21M
Net income continuous operations
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
34.94%-4.16M
-30.59%-22.58M
44.86%-3.21M
Noncontrolling interests
Net income attributable to the company
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
34.94%-4.16M
-30.59%-22.58M
44.86%-3.21M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-336.20%-4.98M
-315.51%-3.72M
31.12%-2.86M
55.49%-10.05M
-20.27%-3.86M
76.26%-1.14M
89.04%-896K
34.94%-4.16M
-30.59%-22.58M
44.86%-3.21M
Diluted earnings per share
-250.00%-0.07
-400.00%-0.05
42.86%-0.04
61.90%-0.16
0.00%-0.06
77.78%-0.02
93.33%-0.01
41.67%-0.07
-20.00%-0.42
45.45%-0.06
Basic earnings per share
-250.00%-0.07
-400.00%-0.05
42.86%-0.04
61.90%-0.16
0.00%-0.06
77.78%-0.02
93.33%-0.01
41.67%-0.07
-20.00%-0.42
45.45%-0.06
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -2.93%4.78M33.23%5.44M2.98%4.46M-27.46%16.3M-4.99%2.97M0.49%4.92M-50.43%4.08M-30.34%4.33M29.19%22.47M-45.24%3.13M
Selling and administrative expenses -9.63%1.78M34.07%2.3M-14.23%1.65M-9.40%6.99M-28.25%1.38M-0.30%1.97M-12.13%1.72M3.34%1.92M19.04%7.72M-3.50%1.93M
-General and administrative expense -9.63%1.78M34.07%2.3M-14.23%1.65M-9.40%6.99M-28.25%1.38M-0.30%1.97M-12.13%1.72M3.34%1.92M19.04%7.72M-3.50%1.93M
Research and development costs 1.56%2.99M32.68%3.13M16.63%2.81M-36.78%9.3M33.17%1.59M1.31%2.95M-62.32%2.36M-44.56%2.41M35.38%14.72M-67.82%1.19M
Depreciation amortization depletion 0.00%2K-50.00%1K--1K-86.49%5K-85.71%1K-80.00%2K-80.00%2K--0-7.50%37K-30.00%7K
-Depreciation and amortization 0.00%2K-50.00%1K--1K-86.49%5K-85.71%1K-80.00%2K-80.00%2K--0-7.50%37K-30.00%7K
Operating profit 2.93%-4.78M-33.23%-5.44M-2.98%-4.46M27.46%-16.3M4.99%-2.97M-0.49%-4.92M50.43%-4.08M30.34%-4.33M-29.19%-22.47M45.24%-3.13M
Net non-operating interest income (expenses) -17.06%282K111.11%342K1,053.33%346K1,224.64%914K4,144.44%382K2,025.00%340K671.43%162K30.43%30K-78.03%69K-66.67%9K
Non-operating interest income -17.06%282K111.11%342K1,053.33%346K1,224.64%914K4,144.44%382K2,025.00%340K671.43%162K30.43%30K-78.03%69K-66.67%9K
Other net income (expenses) -114.01%-482K-54.61%1.37M762.76%1.25M3,187.28%5.34M-1,339.77%-1.27M4,548.65%3.44M8,791.18%3.02M175.13%145K16.83%-173K32.82%-88K
Gain on sale of security -114.01%-482K-54.61%1.37M762.76%1.25M3,187.28%5.34M-1,339.77%-1.27M4,548.65%3.44M8,791.18%3.02M175.13%145K16.83%-173K32.82%-88K
Income before tax -336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K34.94%-4.16M-30.59%-22.58M44.86%-3.21M
Income tax
Earnings from equity interest net of tax
Net income -336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K34.94%-4.16M-30.59%-22.58M44.86%-3.21M
Net income continuous operations -336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K34.94%-4.16M-30.59%-22.58M44.86%-3.21M
Noncontrolling interests
Net income attributable to the company -336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K34.94%-4.16M-30.59%-22.58M44.86%-3.21M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -336.20%-4.98M-315.51%-3.72M31.12%-2.86M55.49%-10.05M-20.27%-3.86M76.26%-1.14M89.04%-896K34.94%-4.16M-30.59%-22.58M44.86%-3.21M
Diluted earnings per share -250.00%-0.07-400.00%-0.0542.86%-0.0461.90%-0.160.00%-0.0677.78%-0.0293.33%-0.0141.67%-0.07-20.00%-0.4245.45%-0.06
Basic earnings per share -250.00%-0.07-400.00%-0.0542.86%-0.0461.90%-0.160.00%-0.0677.78%-0.0293.33%-0.0141.67%-0.07-20.00%-0.4245.45%-0.06
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg